This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Data for the study was gathered from comprehensive administrative health and demographic data in Canada by the Institute for Clinical Evaluative Sciences from January 2020 to November 2023. Of the included patients, 46334 were exposed to GLP-1s for longer than 6 months and 92668 were unexposed. JAMA Ophthalmol. 2022;140(12):1202–1208.
link] Recent Videos Related Content FDA Grants Expanded Interchangeability Designation to Yuflyma Ashley Gallagher May 23rd 2025 Article Adalimumab-aaty (Yuflyma) prefilled syringes and autoinjectors are now fully interchangeable with the reference product adalimumab (Humira) across marketed dosage forms and strengths. Mayo Clinic.
1 Natural disasters have reached unprecedented levels in the past 5 years, with 2020, 2023, and 2024 being the most destructive and costly since before 1980. Taking precautions for storing medications and supplies is key to being prepared,” the FDA wrote.
Published 2023 Nov 3. Published 2025 Jun 13. doi:10.1186/s13098-025-01777-7 2. The Link Between Sleeping and Type 2 Diabetes: A Systematic Review. 2023;15(11):e48228. doi:10.7759/cureus.48228 Henson J, Covenant A, Hall AP, et al. Waking Up to the Importance of Sleep in Type 2 Diabetes Management: A Narrative Review. Diabetes Care.
READ MORE: FDA Approves Roflumilast Foam For Plaque Psoriasis of Scalp, Body The current treatment guidelines for patients with psoriasis include a variety of pharmacological options, such as biologics, phototherapy, and topicals. October 2023. J Dermatol Treat. 2025;36(1). Accessed June 11, 2025. Psoriatic arthritis.
In April 2023, a total of 4.8 On February 6, 2023, researchers conducted the review by searching through a variety of databases using search terms related to skin care and popular social media channels like Facebook and Instagram. March 31, 2023. According to the statistics, [over] 4.26 billion people, or 59.9% 2025;27:e54241.
One of the largest compound pharmacy operations in the U.S. For example, there were 100 instances between November 2022 and March 2023 in which the company found what the FDA called a “significant number” of bacteria, yeast, mold, and other spore-forming organisms.
A medicine based on MDMA – the active ingredient in recreational drug ecstasy – is on the cusp of FDA approval as a treatment for post-traumatic stress disorder (PTSD), according to the organisation developing it. . A second is underway in 100 subjects and if positive could result in a green light for the therapy in 2023.
Food and Drug Administration drug shortage list as of Wednesday , raising the possibility that the medications could soon be taken off the list entirely, a development that could affect compounding pharmacies and patients relying on compounded drugs, STAT reports. The number of layoffs in the U.S.
Draft guidance published by the US Food and Drug Administration (FDA) in December 2023, discussed quality considerations for topical ophthalmic drug products, including key considerations for extractables and leachables (E&L) testing. This document is revised from a version published in October 2023.
Claud — The Office of Compliance (OC) at FDA’s Center for Drug Evaluation and Research (CDER) had a role in many of the major public health enforcement matters you may have read about last year. Some takeaways on those efforts that we gleaned from the report: Compounding. Drug Supply Chain. Clinical Trials.
Related Videos Related Content Advertisement June 20th 2025 FDA Approves Dupilumb for Treatment of Bullous Pemphigoid Aislinn Antrim, Managing Editor May 28th 2025 Pharmacy Focus: Navigating Seasonal Allergies Luke Halpern, Assistant Editor Derek Webb, PharmD June 20th 2025 Self-Care Measures for Preventing and Managing Dysmenorrhea Yvette C.
Claud — Last week, FDA revised one of its two guidances relating to nitrosamines, Control of Nitrosamine Impurities in Human Drugs. FDA starts by setting the limit of what it views as acceptable intake (AI) limits, so that manufacturers and applicants can know what targets they should hit. By John W.M.
THC acetate esters are different than delta-9-THC, the psychoactive compound found naturally in the cannabis plant. 13, 2023). Dr. Boos explained that delta-9-THCO and delta-8-THCO have similar chemical structures and pharmacological activities as compounds in the cannabis plant so they fall within the definition of THC.
Unlike Ozempic, which is FDA approved to treat Type 2 diabetes, Wegovy is approved for weight loss in patients with a body mass index (BMI) of 30 or higher and in patients with a BMI of 27 or higher who also have a weight-related medical condition like Type 2 diabetes, high blood pressure, or high cholesterol.
They provided this compound to John Hopkins University who received a grant of nearly $4 million from the National Institutes of Health (NIH) for their smoking cessation study in the US – the first time in 50 years the US government has funded a study evaluating a psychedelic compound for therapeutic use.
One person also experienced hypoglycemia in 2023 after injecting a compounded version of Ozempic, said the organization, which represents 55 regional poison centers across the country and works with the U.S. … Three people sought medical treatment for dangerously low blood sugar in the U.S.
The US Food and Drug Administration (FDA) has accepted Outlook Therapeutics’ Biologics License Application (BLA) filing for ONS-5010 / LYTENAVA (bevacizumab-vikg) to treat wet age-related macular degeneration (wet AMD). The regulator has set 29 August 2023 as a Prescription Drug User Fee Act (PDUFA) goal date.
In the published in 2023, the process and requirements for toxicological risk assessment of medical device constituents is outlined. The guideline states that compounds “at or above the AET must be reported for toxicological risk assessment.”
Anima uses its mRNA Lightning platform to discover small molecules and determine their mechanisms of action for diseases previously deemed undruggable, with scientists searching for compounds that target proteins with roles in regulating mRNA, so as to affect disease states through post-transcriptional regulation (i.e.
Novo Nordisk’s leading drug Ozempic (semaglutide) is forecast to demonstrate a sales growth of 23% in 2023. Ozempic’s forecast 2023 sales of $12.5bn consolidate its position as the dominant market leader, with projected sales in 2023 54% greater than closest competitor Trulicity (dulaglutide) by Eli Lilly, which anticipates sales of $8bn.
While this is essential in the interrogation of novel compounds for which we know very little about their efficacy and safety, it is also true that some biomedical research is highly wasteful. It is estimated that only one in 10 drugs that enter Phase I trials are subsequently licensed by the US Food and Drug Administration (FDA).
Recent industry comments submitted to FDA and new, international efforts against these nefarious, potentially carcinogenic organic compounds have the shifting state of regulation here back in the news. What is FDA doing about NDRSIs? Seek, and ye shall find, so FDA hopes. By John W.M. Claud & Sara W.
News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)
Although Ozempic has been approved by the Food and Drug Administration (FDA) since 2017, its status as a household name is relatively recent. Weight loss is an off-label , non-FDA-approved use for Ozempic. The FDA has urged consumers to use caution when taking medication from these compound pharmacies.
Supporting the successful compounding of drugs with 3D printing processes has the potential to not only fulfil unmet patient needs but also drive efficiencies in hospital pharmacies. 2 The first drug produced through printing technology based on inkjet on powder was approved by the US FDA in 2015.
OAI is FDA’s classification for facilities it deems to be in an unacceptable state of compliance. One inspection resulted in FDA’s securing a consent decree to restrict or shut down operations, and two resulted in an “untitled letter,” which is not available to the public on FDA’s website.
Additionally, in June 2023, the world’s largest radionuclide production facility of lutetium-177 opened in Germany. With alpha particles, you must be very careful how the drug is made to ensure that the compound remains stable between manufacturing and use. Recent advancements for radiopharmaceuticals in oncology include a $1.4
Published date: 21/02/2023 Summary: ● This is the first time the FDA has given IND approval for a Phase IIb study of a short-acting psychedelic like 5-MeO-DMT (Mebufotenin). The study will take place across 40 investigator sites in 7 different countries, with study results expected in 2024. read more
Shots: The US FDA has accepted the NDA for Priority Review of ADX-2191 (methotrexate injection) for PVRL. The therapy received ODD from the US FDA for PVR, PVRL, and retinitis pigmentosa Ref: Aldeyra | Image: Aldeyra Related Post:- Aldeyra Therapeutics Reports the US FDA Acceptance of NDA for Reproxalap to Treat Dry Eye Disease
Published date: 05/01/2023. Summary: • TMP-301 (formerly HTL0014242) is a potent, selective, and orally available mGluR5 negative allosteric modulator (NAM) candidate discovered by Sosei Heptares and out-licensed to Tempero Bio • Phase 1 study in healthy volunteers expected to begin in Q1 2023 with support from a US$5.3M read more.
Over 80 million Americans received Medicaid assistance in 2023, and it sometimes covers Mounjaro for diabetes treatment. Look into compounded options (but be careful). Medicaid is a federal- and state-funded program that provides free or steeply discounted health insurance, often including coverage for prescription drugs.
Supplement with turmeric Curcumin is the main compound of the herb turmeric, and according to Dr. Garcia-Ibáñez, it works as a powerful antioxidant and anti-inflammatory. Garlic Garlic does contain anti-inflammatory compounds that, in theory, might reduce congestion. StatPearls (2023) Nasal Congestion. That’s because only 0.5-2%
This challenge is further compounded by increasingly complex drug formulations and global ingredient supply chains that stretch manufacturers’ capabilities in testing and control of impurities. But with the spate of recalls, the FDA developed a Guidance for Industry on Control of Nitrosamine Impurities in Human Drugs. Internet] 2023.
1 More recently, regulators like the FDA have increasingly promoted the benefits of modeling (e.g., For a more in-depth review of these topics, including Q&A, register for the ISPE webinar “Advance Biopharma Tech Transfer Using Process Modeling & Simulation”, on Thursday, 4 May 2023 at 1000 ET. Register Now! 1 Harrison, Roger G.,
In the US, botanical dietary supplements can be sold without US Food and Drug Administration (FDA) approval, 1 prompting many vendors to promote the use of botanical products as dietary supplements , 2 rather than pursue a path of regulatory approval. 3 Is two too few? 3 Is two too few?
You may be familiar with naltrexone, which is an FDA-approved medication that has been used since the 1980s for opioid withdrawal. LDN can be taken in the form of a compounded tablet, capsule, liquid, or transdermal formulation. It’s also best to work with a compounding pharmacy that can help you titrate your dose correctly.
That compound (previously called TAK-580) was taken into a phase 1/2b trial in children with the brain cancer glioma before the Japanese drugmaker returned the rights after a review of its pipeline assets. It says the FDA has suggested that study could form the basis of a regulatory filing if response rate data are positive.
For people with Type 2 diabetes, Ozempic is a game-changer: This FDA-approved drug not only lowers blood sugar but can also help people lose weight. UC Davis Health (2023) Diabetes , World Health Organization (2023) GLP-1 Agonists , Cleveland Clinic (2023) Fats. MedlinePlus Curious About Ozempic?
Phenylephrine In September 2023, the FDA announced that a common decongestant found on shelves, phenylephrine, is not actually effective to decrease congestion. Some studies suggest curcumin, the active compound in turmeric, may even have antiviral properties. Here’s what to skip. or make an anti-inflammatory chicken soup.
These closures, compounded by the decline of independent pharmacies, create a critical gap in care. Image Maggie McCullough 12 June, 2025 pharmacy deserts Bookmark this Oncology ImmunityBio’s ANKTIVA & FDA Expanded Access: Transforming bl. These closures put medication access, affordability, and adherence at greater risk.
Help your patients access the hottest weight loss medications with these semaglutide and tirzepatide resources for independent pharmacy owners, whether you compound or not. Is It Legal To Compound Semaglutide and Tirzepatide? Some states might have you check the list every day you compound with either of these APIs (i.e.,
Regulatory and Policy Implications Key Takeaways ·ACIP overhaul disrupts vaccine approval timelines, posing risks to clinical trial planning, FDA readiness, and seasonal launch strategies. The news follows announcements in March of a restructuring to include the reduction of HHS workforce by 10,000 full-time employees.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content